Large gap with delayed quotes
|
Last quote
12/15/2025
-
22:15:00
|
Bid
12/15/2025 -
21:59:59
|
Bid Volume |
Ask
12/15/2025 -
21:59:59
|
Ask Volume |
|---|---|---|---|---|
|
86.50
-0.20
(
-0.23% )
|
86.49
|
1,400 |
86.54
|
2,200 |
Analysis date: 12.12.2025
Global Evaluation
Slightly negative
Slightly negative
The stock is classified in the slightly negative zone since 12.12.2025.
Interest
Strong
Strong
Three stars since 04.11.2025.
Earnings Rev Trend
Positive
Positive
Compared to seven weeks ago, the analysts have raised their earnings per share estimates. This positive trend began 17.10.2025 at a price of 59.58.
Evaluation
Strongly overvalued
Strongly overvalued
Based on its growth potential and our own criteria, we believe the share price is currently overvalued.
MT Tech Trend
Positive
Positive
The dividend-adjusted forty day technical trend is positive since 17.10.2025.
4wk Rel Perf
2.35%
2.35%
The four-week dividend-adjusted overperformance versus SP500 is 2.35%.
Sensibility
High
High
The stock has been on the high-sensitivity level since 12.12.2025.
Bear Market Factor
Low
Low
On average, the stock has a tendency to minimize the drops in the index by -0.50%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 3.48%.
Mkt Cap in $bn
11.96
11.96
With a market capitalization >$8bn, GLOBUS MEDICAL INCO. is considered a large-cap stock.
G/PE Ratio
0.77
0.77
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) below 0.9 indicates that investors must pay a premium for the estimated growth potential:
LT P/E
16.90
16.90
The estimated PE is for the year 2027.
LT Growth
13.02%
13.02%
The annualized growth estimate is for the current year to 2027.
Avg. Nb analysts
12
12
Over the last seven weeks, an average of 12 analysts provided earnings per share estimates.
Dividend Yield
0.00%
0.00%
The company is not paying a dividend.
Beta
81
81
For 1% of index variation, the stock varies on average by 0.81%.
Correlation
0.30
0.30
Stock movements are strongly independent of index variations.
Value at Risk
43.15
43.15
The value at risk is estimated at USD 43.15. The risk is therefore 49.77%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
27.07.2018
27.07.2018